nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0931	0.191	CbGbCtD
Fluphenazine—CYP1A2—Leflunomide—systemic scleroderma	0.0888	0.182	CbGbCtD
Fluphenazine—ABCB1—Lisinopril—systemic scleroderma	0.0814	0.167	CbGbCtD
Fluphenazine—ABCB1—Captopril—systemic scleroderma	0.061	0.125	CbGbCtD
Fluphenazine—CYP2D6—Captopril—systemic scleroderma	0.0574	0.118	CbGbCtD
Fluphenazine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.048	0.0985	CbGbCtD
Fluphenazine—ABCB1—Prednisone—systemic scleroderma	0.0384	0.0787	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—systemic scleroderma	0.0192	0.0395	CbGbCtD
Fluphenazine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0113	0.113	CbGeAlD
Fluphenazine—HTR2A—pulmonary artery—systemic scleroderma	0.00798	0.0803	CbGeAlD
Fluphenazine—CALM2—artery—systemic scleroderma	0.00488	0.0491	CbGeAlD
Fluphenazine—CALM1—artery—systemic scleroderma	0.00485	0.0489	CbGeAlD
Fluphenazine—CALM2—endothelium—systemic scleroderma	0.00412	0.0415	CbGeAlD
Fluphenazine—CALM1—endothelium—systemic scleroderma	0.0041	0.0413	CbGeAlD
Fluphenazine—CALM2—blood vessel—systemic scleroderma	0.0038	0.0383	CbGeAlD
Fluphenazine—CALM1—blood vessel—systemic scleroderma	0.00378	0.0381	CbGeAlD
Fluphenazine—HTR2A—artery—systemic scleroderma	0.00296	0.0298	CbGeAlD
Fluphenazine—HTR2A—endothelium—systemic scleroderma	0.0025	0.0252	CbGeAlD
Fluphenazine—HTR2A—blood vessel—systemic scleroderma	0.0023	0.0232	CbGeAlD
Fluphenazine—CALM3—smooth muscle tissue—systemic scleroderma	0.00227	0.0229	CbGeAlD
Fluphenazine—Hepatocellular injury—Leflunomide—systemic scleroderma	0.00219	0.00608	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.00214	0.00595	CcSEcCtD
Fluphenazine—Hepatocellular injury—Mycophenolic acid—systemic scleroderma	0.00208	0.0058	CcSEcCtD
Fluphenazine—Renal failure acute—Captopril—systemic scleroderma	0.00208	0.0058	CcSEcCtD
Fluphenazine—Pancytopenia—Pentoxifylline—systemic scleroderma	0.00208	0.0058	CcSEcCtD
Fluphenazine—Abnormal dreams—Mycophenolic acid—systemic scleroderma	0.00206	0.00573	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00204	0.00568	CcSEcCtD
Fluphenazine—Menstruation irregular—Prednisone—systemic scleroderma	0.00201	0.00561	CcSEcCtD
Fluphenazine—Leukocytosis—Lisinopril—systemic scleroderma	0.002	0.00556	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Captopril—systemic scleroderma	0.00199	0.00553	CcSEcCtD
Fluphenazine—Blood disorder—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00548	CcSEcCtD
Fluphenazine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00196	0.00545	CcSEcCtD
Fluphenazine—Liver injury—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00544	CcSEcCtD
Fluphenazine—CALM2—connective tissue—systemic scleroderma	0.00195	0.0196	CbGeAlD
Fluphenazine—CALM1—connective tissue—systemic scleroderma	0.00194	0.0195	CbGeAlD
Fluphenazine—Asthma—Mometasone—systemic scleroderma	0.00189	0.00527	CcSEcCtD
Fluphenazine—Appetite absent—Methotrexate—systemic scleroderma	0.00187	0.00521	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00521	CcSEcCtD
Fluphenazine—Cardiac arrest—Captopril—systemic scleroderma	0.00183	0.00509	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Lisinopril—systemic scleroderma	0.00182	0.00507	CcSEcCtD
Fluphenazine—CALM2—smooth muscle tissue—systemic scleroderma	0.00178	0.0179	CbGeAlD
Fluphenazine—CALM1—smooth muscle tissue—systemic scleroderma	0.00177	0.0179	CbGeAlD
Fluphenazine—Eczema—Leflunomide—systemic scleroderma	0.00177	0.00491	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Mometasone—systemic scleroderma	0.00176	0.0049	CcSEcCtD
Fluphenazine—CALM2—skin of body—systemic scleroderma	0.00176	0.0177	CbGeAlD
Fluphenazine—CALM1—skin of body—systemic scleroderma	0.00175	0.0176	CbGeAlD
Fluphenazine—Leukocytosis—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00487	CcSEcCtD
Fluphenazine—CALM3—tendon—systemic scleroderma	0.0017	0.0172	CbGeAlD
Fluphenazine—Eosinophilia—Captopril—systemic scleroderma	0.00165	0.00458	CcSEcCtD
Fluphenazine—Hepatocellular injury—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00458	CcSEcCtD
Fluphenazine—Renal failure acute—Mycophenolic acid—systemic scleroderma	0.00164	0.00456	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.00164	0.00456	CcSEcCtD
Fluphenazine—Pancytopenia—Captopril—systemic scleroderma	0.00158	0.0044	CcSEcCtD
Fluphenazine—Photosensitivity—Lisinopril—systemic scleroderma	0.00155	0.00432	CcSEcCtD
Fluphenazine—Erythema—Pentoxifylline—systemic scleroderma	0.00153	0.00426	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Captopril—systemic scleroderma	0.00152	0.00423	CcSEcCtD
Fluphenazine—Eczema—Lisinopril—systemic scleroderma	0.00152	0.00422	CcSEcCtD
Fluphenazine—ABCB1—blood vessel—systemic scleroderma	0.00151	0.0152	CbGeAlD
Fluphenazine—Dermatitis atopic—Prednisone—systemic scleroderma	0.00151	0.00419	CcSEcCtD
Fluphenazine—Nasal congestion—Lisinopril—systemic scleroderma	0.0015	0.00416	CcSEcCtD
Fluphenazine—CALM3—lung—systemic scleroderma	0.0015	0.0151	CbGeAlD
Fluphenazine—Glaucoma—Prednisone—systemic scleroderma	0.00148	0.00412	CcSEcCtD
Fluphenazine—Renal failure acute—Lisinopril—systemic scleroderma	0.00148	0.00411	CcSEcCtD
Fluphenazine—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.00147	0.0041	CcSEcCtD
Fluphenazine—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00147	0.00409	CcSEcCtD
Fluphenazine—Vision blurred—Pentoxifylline—systemic scleroderma	0.00144	0.00401	CcSEcCtD
Fluphenazine—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00144	0.004	CcSEcCtD
Fluphenazine—HRH1—connective tissue—systemic scleroderma	0.00141	0.0142	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00141	0.00392	CcSEcCtD
Fluphenazine—CALM2—digestive system—systemic scleroderma	0.00141	0.0142	CbGeAlD
Fluphenazine—Agitation—Pentoxifylline—systemic scleroderma	0.00141	0.00391	CcSEcCtD
Fluphenazine—CALM1—digestive system—systemic scleroderma	0.0014	0.0141	CbGeAlD
Fluphenazine—Angioedema—Pentoxifylline—systemic scleroderma	0.0014	0.00389	CcSEcCtD
Fluphenazine—ADRA2A—connective tissue—systemic scleroderma	0.00139	0.014	CbGeAlD
Fluphenazine—Agranulocytosis—Captopril—systemic scleroderma	0.00138	0.00385	CcSEcCtD
Fluphenazine—Pancytopenia—Azathioprine—systemic scleroderma	0.00138	0.00384	CcSEcCtD
Fluphenazine—Asthma—Leflunomide—systemic scleroderma	0.00137	0.00382	CcSEcCtD
Fluphenazine—Leukopenia—Pentoxifylline—systemic scleroderma	0.00137	0.00381	CcSEcCtD
Fluphenazine—Eosinophilia—Leflunomide—systemic scleroderma	0.00136	0.00378	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Lisinopril—systemic scleroderma	0.00135	0.00376	CcSEcCtD
Fluphenazine—CALM2—tendon—systemic scleroderma	0.00134	0.0135	CbGeAlD
Fluphenazine—CALM1—tendon—systemic scleroderma	0.00133	0.0134	CbGeAlD
Fluphenazine—Hypertension—Pentoxifylline—systemic scleroderma	0.00132	0.00367	CcSEcCtD
Fluphenazine—Dysphagia—Mycophenolic acid—systemic scleroderma	0.00131	0.00364	CcSEcCtD
Fluphenazine—Asthma—Mycophenolic acid—systemic scleroderma	0.00131	0.00364	CcSEcCtD
Fluphenazine—Pancytopenia—Leflunomide—systemic scleroderma	0.0013	0.00362	CcSEcCtD
Fluphenazine—Pneumonia—Azathioprine—systemic scleroderma	0.0013	0.00362	CcSEcCtD
Fluphenazine—Cardiac arrest—Lisinopril—systemic scleroderma	0.0013	0.00361	CcSEcCtD
Fluphenazine—HRH1—smooth muscle tissue—systemic scleroderma	0.00129	0.013	CbGeAlD
Fluphenazine—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.00129	0.0036	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.00127	0.00355	CcSEcCtD
Fluphenazine—Dry mouth—Pentoxifylline—systemic scleroderma	0.00127	0.00354	CcSEcCtD
Fluphenazine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00125	0.00347	CcSEcCtD
Fluphenazine—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00124	0.00346	CcSEcCtD
Fluphenazine—Pneumonia—Leflunomide—systemic scleroderma	0.00123	0.00342	CcSEcCtD
Fluphenazine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00122	0.00339	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.00122	0.00338	CcSEcCtD
Fluphenazine—Skin disorder—Pentoxifylline—systemic scleroderma	0.00121	0.00337	CcSEcCtD
Fluphenazine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00121	0.00336	CcSEcCtD
Fluphenazine—Angioedema—Mometasone—systemic scleroderma	0.00121	0.00336	CcSEcCtD
Fluphenazine—Leukocytosis—Prednisone—systemic scleroderma	0.00119	0.0033	CcSEcCtD
Fluphenazine—HTR2A—connective tissue—systemic scleroderma	0.00118	0.0119	CbGeAlD
Fluphenazine—Asthma—Lisinopril—systemic scleroderma	0.00118	0.00328	CcSEcCtD
Fluphenazine—CALM2—lung—systemic scleroderma	0.00117	0.0118	CbGeAlD
Fluphenazine—Pneumonia—Mycophenolic acid—systemic scleroderma	0.00117	0.00326	CcSEcCtD
Fluphenazine—CALM1—lung—systemic scleroderma	0.00117	0.0118	CbGeAlD
Fluphenazine—Eosinophilia—Lisinopril—systemic scleroderma	0.00117	0.00325	CcSEcCtD
Fluphenazine—Hypotension—Pentoxifylline—systemic scleroderma	0.00117	0.00325	CcSEcCtD
Fluphenazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00114	0.00317	CcSEcCtD
Fluphenazine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00316	CcSEcCtD
Fluphenazine—Pancytopenia—Lisinopril—systemic scleroderma	0.00112	0.00311	CcSEcCtD
Fluphenazine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00111	0.0031	CcSEcCtD
Fluphenazine—Somnolence—Pentoxifylline—systemic scleroderma	0.00111	0.00309	CcSEcCtD
Fluphenazine—Dry mouth—Mometasone—systemic scleroderma	0.0011	0.00306	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00109	0.00305	CcSEcCtD
Fluphenazine—Vision blurred—Captopril—systemic scleroderma	0.00109	0.00304	CcSEcCtD
Fluphenazine—CYP1A2—digestive system—systemic scleroderma	0.00109	0.011	CbGeAlD
Fluphenazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00109	0.00303	CcSEcCtD
Fluphenazine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00109	0.00302	CcSEcCtD
Fluphenazine—Oedema peripheral—Leflunomide—systemic scleroderma	0.00108	0.00301	CcSEcCtD
Fluphenazine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00108	0.0109	CbGeAlD
Fluphenazine—DRD2—lung—systemic scleroderma	0.00108	0.0109	CbGeAlD
Fluphenazine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00108	0.003	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00108	0.00299	CcSEcCtD
Fluphenazine—Constipation—Pentoxifylline—systemic scleroderma	0.00107	0.00297	CcSEcCtD
Fluphenazine—Angioedema—Captopril—systemic scleroderma	0.00106	0.00295	CcSEcCtD
Fluphenazine—Pneumonia—Lisinopril—systemic scleroderma	0.00106	0.00294	CcSEcCtD
Fluphenazine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00287	CcSEcCtD
Fluphenazine—Dysphagia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00287	CcSEcCtD
Fluphenazine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00103	0.00287	CcSEcCtD
Fluphenazine—HRH1—digestive system—systemic scleroderma	0.00102	0.0103	CbGeAlD
Fluphenazine—Urticaria—Pentoxifylline—systemic scleroderma	0.000992	0.00276	CcSEcCtD
Fluphenazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000987	0.00275	CcSEcCtD
Fluphenazine—CYP2E1—digestive system—systemic scleroderma	0.000982	0.00989	CbGeAlD
Fluphenazine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00098	0.00273	CcSEcCtD
Fluphenazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00098	0.00273	CcSEcCtD
Fluphenazine—HRH1—tendon—systemic scleroderma	0.000972	0.00979	CbGeAlD
Fluphenazine—Dry mouth—Captopril—systemic scleroderma	0.000965	0.00269	CcSEcCtD
Fluphenazine—Dyspnoea—Mometasone—systemic scleroderma	0.00096	0.00267	CcSEcCtD
Fluphenazine—ADRA2A—tendon—systemic scleroderma	0.000955	0.00962	CbGeAlD
Fluphenazine—Anaphylactic shock—Captopril—systemic scleroderma	0.000946	0.00263	CcSEcCtD
Fluphenazine—Decreased appetite—Mometasone—systemic scleroderma	0.000936	0.00261	CcSEcCtD
Fluphenazine—CYP2E1—tendon—systemic scleroderma	0.000934	0.00941	CbGeAlD
Fluphenazine—Oedema peripheral—Lisinopril—systemic scleroderma	0.000929	0.00258	CcSEcCtD
Fluphenazine—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.000926	0.00258	CcSEcCtD
Fluphenazine—Tachycardia—Captopril—systemic scleroderma	0.000923	0.00257	CcSEcCtD
Fluphenazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00092	0.00256	CcSEcCtD
Fluphenazine—Muscle spasms—Leflunomide—systemic scleroderma	0.000918	0.00256	CcSEcCtD
Fluphenazine—CYP1A2—lung—systemic scleroderma	0.000911	0.00918	CbGeAlD
Fluphenazine—Leukopenia—Azathioprine—systemic scleroderma	0.000905	0.00252	CcSEcCtD
Fluphenazine—Vision blurred—Leflunomide—systemic scleroderma	0.0009	0.00251	CcSEcCtD
Fluphenazine—Hypotension—Captopril—systemic scleroderma	0.000884	0.00246	CcSEcCtD
Fluphenazine—Pruritus—Pentoxifylline—systemic scleroderma	0.000883	0.00246	CcSEcCtD
Fluphenazine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000876	0.00244	CcSEcCtD
Fluphenazine—Angioedema—Leflunomide—systemic scleroderma	0.000873	0.00243	CcSEcCtD
Fluphenazine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000859	0.00239	CcSEcCtD
Fluphenazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000859	0.00239	CcSEcCtD
Fluphenazine—Leukopenia—Leflunomide—systemic scleroderma	0.000855	0.00238	CcSEcCtD
Fluphenazine—HTR2A—digestive system—systemic scleroderma	0.000853	0.00859	CbGeAlD
Fluphenazine—HRH1—lung—systemic scleroderma	0.000853	0.00859	CbGeAlD
Fluphenazine—Body temperature increased—Mometasone—systemic scleroderma	0.000851	0.00237	CcSEcCtD
Fluphenazine—Dyspnoea—Captopril—systemic scleroderma	0.000843	0.00235	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—systemic scleroderma	0.000843	0.00234	CcSEcCtD
Fluphenazine—Somnolence—Captopril—systemic scleroderma	0.000841	0.00234	CcSEcCtD
Fluphenazine—ADRA2A—lung—systemic scleroderma	0.000838	0.00844	CbGeAlD
Fluphenazine—Agitation—Mycophenolic acid—systemic scleroderma	0.000837	0.00233	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.000834	0.00232	CcSEcCtD
Fluphenazine—Lethargy—Prednisone—systemic scleroderma	0.000826	0.0023	CcSEcCtD
Fluphenazine—Hypertension—Leflunomide—systemic scleroderma	0.000825	0.0023	CcSEcCtD
Fluphenazine—Decreased appetite—Captopril—systemic scleroderma	0.000822	0.00229	CcSEcCtD
Fluphenazine—Erythema—Lisinopril—systemic scleroderma	0.000821	0.00228	CcSEcCtD
Fluphenazine—CYP2E1—lung—systemic scleroderma	0.00082	0.00826	CbGeAlD
Fluphenazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000816	0.00227	CcSEcCtD
Fluphenazine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000814	0.00226	CcSEcCtD
Fluphenazine—HTR2A—tendon—systemic scleroderma	0.000812	0.00818	CbGeAlD
Fluphenazine—Constipation—Captopril—systemic scleroderma	0.000809	0.00225	CcSEcCtD
Fluphenazine—Skin disorder—Azathioprine—systemic scleroderma	0.000802	0.00223	CcSEcCtD
Fluphenazine—Dry mouth—Leflunomide—systemic scleroderma	0.000795	0.00221	CcSEcCtD
Fluphenazine—Muscle spasms—Lisinopril—systemic scleroderma	0.000789	0.0022	CcSEcCtD
Fluphenazine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000787	0.00219	CcSEcCtD
Fluphenazine—Headache—Pentoxifylline—systemic scleroderma	0.000782	0.00218	CcSEcCtD
Fluphenazine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00078	0.00217	CcSEcCtD
Fluphenazine—CYP2D6—digestive system—systemic scleroderma	0.000777	0.00783	CbGeAlD
Fluphenazine—Vision blurred—Lisinopril—systemic scleroderma	0.000774	0.00215	CcSEcCtD
Fluphenazine—Hypotension—Azathioprine—systemic scleroderma	0.000771	0.00215	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—systemic scleroderma	0.00077	0.00214	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—systemic scleroderma	0.00077	0.00214	CcSEcCtD
Fluphenazine—Cardiac arrest—Prednisone—systemic scleroderma	0.00077	0.00214	CcSEcCtD
Fluphenazine—Pruritus—Mometasone—systemic scleroderma	0.000762	0.00212	CcSEcCtD
Fluphenazine—Tachycardia—Leflunomide—systemic scleroderma	0.000761	0.00212	CcSEcCtD
Fluphenazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000759	0.00211	CcSEcCtD
Fluphenazine—Skin disorder—Leflunomide—systemic scleroderma	0.000757	0.00211	CcSEcCtD
Fluphenazine—Angioedema—Lisinopril—systemic scleroderma	0.00075	0.00209	CcSEcCtD
Fluphenazine—Body temperature increased—Captopril—systemic scleroderma	0.000748	0.00208	CcSEcCtD
Fluphenazine—Nausea—Pentoxifylline—systemic scleroderma	0.000741	0.00206	CcSEcCtD
Fluphenazine—Leukopenia—Lisinopril—systemic scleroderma	0.000735	0.00204	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—systemic scleroderma	0.000733	0.00204	CcSEcCtD
Fluphenazine—Hypotension—Leflunomide—systemic scleroderma	0.000729	0.00203	CcSEcCtD
Fluphenazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000726	0.00202	CcSEcCtD
Fluphenazine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000722	0.00201	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000717	0.002	CcSEcCtD
Fluphenazine—HTR2A—lung—systemic scleroderma	0.000712	0.00718	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000699	0.00195	CcSEcCtD
Fluphenazine—Dyspnoea—Leflunomide—systemic scleroderma	0.000695	0.00193	CcSEcCtD
Fluphenazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000695	0.00193	CcSEcCtD
Fluphenazine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00192	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—systemic scleroderma	0.00069	0.00192	CcSEcCtD
Fluphenazine—Dry mouth—Lisinopril—systemic scleroderma	0.000683	0.0019	CcSEcCtD
Fluphenazine—Decreased appetite—Leflunomide—systemic scleroderma	0.000678	0.00189	CcSEcCtD
Fluphenazine—Headache—Mometasone—systemic scleroderma	0.000675	0.00188	CcSEcCtD
Fluphenazine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00067	0.00186	CcSEcCtD
Fluphenazine—Pruritus—Captopril—systemic scleroderma	0.000669	0.00186	CcSEcCtD
Fluphenazine—Constipation—Leflunomide—systemic scleroderma	0.000667	0.00186	CcSEcCtD
Fluphenazine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000663	0.00185	CcSEcCtD
Fluphenazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000661	0.00184	CcSEcCtD
Fluphenazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000661	0.00184	CcSEcCtD
Fluphenazine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000657	0.00183	CcSEcCtD
Fluphenazine—Tachycardia—Lisinopril—systemic scleroderma	0.000654	0.00182	CcSEcCtD
Fluphenazine—Body temperature increased—Azathioprine—systemic scleroderma	0.000653	0.00182	CcSEcCtD
Fluphenazine—Skin disorder—Lisinopril—systemic scleroderma	0.000651	0.00181	CcSEcCtD
Fluphenazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000647	0.0018	CcSEcCtD
Fluphenazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000644	0.00179	CcSEcCtD
Fluphenazine—Nausea—Mometasone—systemic scleroderma	0.00064	0.00178	CcSEcCtD
Fluphenazine—Constipation—Mycophenolic acid—systemic scleroderma	0.000636	0.00177	CcSEcCtD
Fluphenazine—Hypotension—Lisinopril—systemic scleroderma	0.000626	0.00174	CcSEcCtD
Fluphenazine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000621	0.00173	CcSEcCtD
Fluphenazine—Urticaria—Leflunomide—systemic scleroderma	0.000619	0.00172	CcSEcCtD
Fluphenazine—Body temperature increased—Leflunomide—systemic scleroderma	0.000616	0.00172	CcSEcCtD
Fluphenazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000608	0.00169	CcSEcCtD
Fluphenazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00167	CcSEcCtD
Fluphenazine—Dyspnoea—Lisinopril—systemic scleroderma	0.000597	0.00166	CcSEcCtD
Fluphenazine—Somnolence—Lisinopril—systemic scleroderma	0.000596	0.00166	CcSEcCtD
Fluphenazine—Headache—Captopril—systemic scleroderma	0.000593	0.00165	CcSEcCtD
Fluphenazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000588	0.00164	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000587	0.00163	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—systemic scleroderma	0.000585	0.00163	CcSEcCtD
Fluphenazine—Decreased appetite—Lisinopril—systemic scleroderma	0.000582	0.00162	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—systemic scleroderma	0.000579	0.00161	CcSEcCtD
Fluphenazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000574	0.0016	CcSEcCtD
Fluphenazine—Constipation—Lisinopril—systemic scleroderma	0.000573	0.00159	CcSEcCtD
Fluphenazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000573	0.00159	CcSEcCtD
Fluphenazine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00057	0.00159	CcSEcCtD
Fluphenazine—Nausea—Captopril—systemic scleroderma	0.000562	0.00156	CcSEcCtD
Fluphenazine—ABCB1—digestive system—systemic scleroderma	0.000559	0.00563	CbGeAlD
Fluphenazine—Pancytopenia—Methotrexate—systemic scleroderma	0.000555	0.00155	CcSEcCtD
Fluphenazine—Pruritus—Leflunomide—systemic scleroderma	0.000552	0.00153	CcSEcCtD
Fluphenazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000548	0.00153	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000543	0.00151	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000534	0.00149	CcSEcCtD
Fluphenazine—Urticaria—Lisinopril—systemic scleroderma	0.000532	0.00148	CcSEcCtD
Fluphenazine—Body temperature increased—Lisinopril—systemic scleroderma	0.00053	0.00147	CcSEcCtD
Fluphenazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000526	0.00146	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—systemic scleroderma	0.000524	0.00146	CcSEcCtD
Fluphenazine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000523	0.00146	CcSEcCtD
Fluphenazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00145	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—systemic scleroderma	0.000521	0.00145	CcSEcCtD
Fluphenazine—Headache—Azathioprine—systemic scleroderma	0.000517	0.00144	CcSEcCtD
Fluphenazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00142	CcSEcCtD
Fluphenazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000502	0.0014	CcSEcCtD
Fluphenazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000494	0.00137	CcSEcCtD
Fluphenazine—Nausea—Azathioprine—systemic scleroderma	0.00049	0.00136	CcSEcCtD
Fluphenazine—Headache—Leflunomide—systemic scleroderma	0.000488	0.00136	CcSEcCtD
Fluphenazine—Erythema—Prednisone—systemic scleroderma	0.000488	0.00136	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000487	0.00135	CcSEcCtD
Fluphenazine—Pruritus—Lisinopril—systemic scleroderma	0.000474	0.00132	CcSEcCtD
Fluphenazine—ABCB1—lung—systemic scleroderma	0.000467	0.0047	CbGeAlD
Fluphenazine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000466	0.0013	CcSEcCtD
Fluphenazine—Headache—Mycophenolic acid—systemic scleroderma	0.000466	0.0013	CcSEcCtD
Fluphenazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000464	0.00129	CcSEcCtD
Fluphenazine—Nausea—Leflunomide—systemic scleroderma	0.000463	0.00129	CcSEcCtD
Fluphenazine—Vision blurred—Prednisone—systemic scleroderma	0.000459	0.00128	CcSEcCtD
Fluphenazine—Agitation—Prednisone—systemic scleroderma	0.000448	0.00125	CcSEcCtD
Fluphenazine—Angioedema—Prednisone—systemic scleroderma	0.000445	0.00124	CcSEcCtD
Fluphenazine—Nausea—Mycophenolic acid—systemic scleroderma	0.000442	0.00123	CcSEcCtD
Fluphenazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000432	0.0012	CcSEcCtD
Fluphenazine—Hypertension—Prednisone—systemic scleroderma	0.000421	0.00117	CcSEcCtD
Fluphenazine—Headache—Lisinopril—systemic scleroderma	0.00042	0.00117	CcSEcCtD
Fluphenazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00116	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—systemic scleroderma	0.000407	0.00113	CcSEcCtD
Fluphenazine—Nausea—Lisinopril—systemic scleroderma	0.000398	0.00111	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000398	0.00111	CcSEcCtD
Fluphenazine—Tachycardia—Prednisone—systemic scleroderma	0.000388	0.00108	CcSEcCtD
Fluphenazine—Skin disorder—Prednisone—systemic scleroderma	0.000386	0.00108	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—systemic scleroderma	0.000384	0.00107	CcSEcCtD
Fluphenazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00102	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—systemic scleroderma	0.000365	0.00101	CcSEcCtD
Fluphenazine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00097	CcSEcCtD
Fluphenazine—Decreased appetite—Prednisone—systemic scleroderma	0.000346	0.000962	CcSEcCtD
Fluphenazine—Constipation—Prednisone—systemic scleroderma	0.00034	0.000947	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000333	0.000925	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—systemic scleroderma	0.000323	0.000899	CcSEcCtD
Fluphenazine—Urticaria—Prednisone—systemic scleroderma	0.000316	0.00088	CcSEcCtD
Fluphenazine—Body temperature increased—Prednisone—systemic scleroderma	0.000315	0.000875	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—systemic scleroderma	0.000311	0.000865	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—systemic scleroderma	0.000296	0.000825	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—systemic scleroderma	0.000296	0.000823	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisone—systemic scleroderma	0.000293	0.000816	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—systemic scleroderma	0.000289	0.000804	CcSEcCtD
Fluphenazine—Pruritus—Prednisone—systemic scleroderma	0.000281	0.000783	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—systemic scleroderma	0.000264	0.000735	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000263	0.000731	CcSEcCtD
Fluphenazine—Headache—Prednisone—systemic scleroderma	0.000249	0.000694	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000245	0.000682	CcSEcCtD
Fluphenazine—Nausea—Prednisone—systemic scleroderma	0.000236	0.000658	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—systemic scleroderma	0.000235	0.000655	CcSEcCtD
Fluphenazine—Headache—Methotrexate—systemic scleroderma	0.000208	0.00058	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—systemic scleroderma	0.000198	0.00055	CcSEcCtD
Fluphenazine—HTR6—Signaling Pathways—HSPG2—systemic scleroderma	5.49e-05	0.00102	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CSK—systemic scleroderma	5.3e-05	0.000981	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—RHOB—systemic scleroderma	5.23e-05	0.000968	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFBI—systemic scleroderma	5.22e-05	0.000965	CbGpPWpGaD
Fluphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	5.12e-05	0.000948	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	5.11e-05	0.000946	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	5.06e-05	0.000936	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	5.06e-05	0.000936	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFBI—systemic scleroderma	5.05e-05	0.000934	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFBI—systemic scleroderma	5.05e-05	0.000934	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—EDN1—systemic scleroderma	5.03e-05	0.000931	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—RHOB—systemic scleroderma	5.01e-05	0.000927	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR ligand binding—CCL2—systemic scleroderma	4.96e-05	0.000918	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	4.95e-05	0.000915	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	4.95e-05	0.000915	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—RHOB—systemic scleroderma	4.94e-05	0.000915	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR ligand binding—CCL2—systemic scleroderma	4.93e-05	0.000913	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SMAD7—systemic scleroderma	4.89e-05	0.000905	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SMAD7—systemic scleroderma	4.81e-05	0.000891	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SMAD7—systemic scleroderma	4.8e-05	0.000889	CbGpPWpGaD
Fluphenazine—DRD1—GPCR downstream signaling—EDN1—systemic scleroderma	4.77e-05	0.000883	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.73e-05	0.000876	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HSPG2—systemic scleroderma	4.72e-05	0.000874	CbGpPWpGaD
Fluphenazine—DRD3—GPCR downstream signaling—EDN1—systemic scleroderma	4.7e-05	0.000871	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HSPG2—systemic scleroderma	4.66e-05	0.000863	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CSK—systemic scleroderma	4.56e-05	0.000845	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CSK—systemic scleroderma	4.5e-05	0.000833	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SMAD7—systemic scleroderma	4.38e-05	0.00081	CbGpPWpGaD
Fluphenazine—DRD2—GPCR ligand binding—CCL2—systemic scleroderma	4.35e-05	0.000806	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CSK—systemic scleroderma	4.35e-05	0.000806	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—EDN1—systemic scleroderma	4.33e-05	0.000801	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—RHOB—systemic scleroderma	4.31e-05	0.000797	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—MMP1—systemic scleroderma	4.29e-05	0.000793	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—RHOB—systemic scleroderma	4.29e-05	0.000793	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR ligand binding—CCL2—systemic scleroderma	4.28e-05	0.000793	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IRF5—systemic scleroderma	4.28e-05	0.000793	CbGpPWpGaD
Fluphenazine—HRH1—GPCR ligand binding—CCL2—systemic scleroderma	4.28e-05	0.000791	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—EDN1—systemic scleroderma	4.27e-05	0.000791	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	4.21e-05	0.000779	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CSK—systemic scleroderma	4.21e-05	0.000779	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CSK—systemic scleroderma	4.21e-05	0.000779	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HSPG2—systemic scleroderma	4.16e-05	0.00077	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IRF5—systemic scleroderma	4.14e-05	0.000767	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IRF5—systemic scleroderma	4.14e-05	0.000767	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—EDN1—systemic scleroderma	4.1e-05	0.000759	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IRF8—systemic scleroderma	4.09e-05	0.000757	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—ITGAM—systemic scleroderma	4.09e-05	0.000757	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD247—systemic scleroderma	4.09e-05	0.000757	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—EDN1—systemic scleroderma	4.08e-05	0.000755	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	4.07e-05	0.000754	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	4.07e-05	0.000754	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HSPG2—systemic scleroderma	4.06e-05	0.000752	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HSPG2—systemic scleroderma	4.04e-05	0.000748	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HSPG2—systemic scleroderma	4.02e-05	0.000745	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HSPG2—systemic scleroderma	4.02e-05	0.000745	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CSK—systemic scleroderma	4.02e-05	0.000744	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	3.99e-05	0.000739	CbGpPWpGaD
Fluphenazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	3.99e-05	0.000738	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	3.98e-05	0.000736	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IRF8—systemic scleroderma	3.96e-05	0.000733	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IRF8—systemic scleroderma	3.96e-05	0.000733	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—ITGAM—systemic scleroderma	3.96e-05	0.000733	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—ITGAM—systemic scleroderma	3.96e-05	0.000733	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD247—systemic scleroderma	3.96e-05	0.000733	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD247—systemic scleroderma	3.96e-05	0.000733	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CSK—systemic scleroderma	3.92e-05	0.000726	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—MMP1—systemic scleroderma	3.91e-05	0.000724	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CSK—systemic scleroderma	3.9e-05	0.000723	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR ligand binding—CCL2—systemic scleroderma	3.9e-05	0.000722	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CSK—systemic scleroderma	3.89e-05	0.000719	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CSK—systemic scleroderma	3.89e-05	0.000719	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	3.86e-05	0.000715	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	3.86e-05	0.000715	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	3.85e-05	0.000712	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	3.85e-05	0.000712	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—TNFAIP3—systemic scleroderma	3.83e-05	0.000709	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—HSPG2—systemic scleroderma	3.82e-05	0.000707	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—BLK—systemic scleroderma	3.79e-05	0.000701	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—MMP1—systemic scleroderma	3.78e-05	0.0007	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—MMP1—systemic scleroderma	3.78e-05	0.0007	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—RHOB—systemic scleroderma	3.78e-05	0.0007	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CD247—systemic scleroderma	3.78e-05	0.000699	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—EDN1—systemic scleroderma	3.72e-05	0.000689	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—RHOB—systemic scleroderma	3.72e-05	0.000689	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—RHOB—systemic scleroderma	3.71e-05	0.000687	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—TNFAIP3—systemic scleroderma	3.71e-05	0.000686	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—TNFAIP3—systemic scleroderma	3.71e-05	0.000686	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—EDN1—systemic scleroderma	3.7e-05	0.000686	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—BLK—systemic scleroderma	3.66e-05	0.000678	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—BLK—systemic scleroderma	3.66e-05	0.000678	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CD247—systemic scleroderma	3.65e-05	0.000676	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CD247—systemic scleroderma	3.65e-05	0.000676	CbGpPWpGaD
Fluphenazine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	3.64e-05	0.000673	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—EDN1—systemic scleroderma	3.6e-05	0.000666	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.59e-05	0.000664	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HSPG2—systemic scleroderma	3.57e-05	0.00066	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—EDN1—systemic scleroderma	3.54e-05	0.000656	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	3.53e-05	0.000654	CbGpPWpGaD
Fluphenazine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	3.52e-05	0.000651	CbGpPWpGaD
Fluphenazine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	3.52e-05	0.000651	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HSPG2—systemic scleroderma	3.51e-05	0.00065	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—HSPG2—systemic scleroderma	3.51e-05	0.000649	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	3.5e-05	0.000648	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—HSPG2—systemic scleroderma	3.48e-05	0.000645	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CSK—systemic scleroderma	3.44e-05	0.000638	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—CCL2—systemic scleroderma	3.44e-05	0.000636	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CSK—systemic scleroderma	3.39e-05	0.000627	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—RHOB—systemic scleroderma	3.39e-05	0.000627	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CSK—systemic scleroderma	3.38e-05	0.000626	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—HSPG2—systemic scleroderma	3.37e-05	0.000624	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—HSPG2—systemic scleroderma	3.37e-05	0.000624	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—EDN1—systemic scleroderma	3.27e-05	0.000605	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—EDN1—systemic scleroderma	3.22e-05	0.000596	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—EDN1—systemic scleroderma	3.22e-05	0.000595	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	3.21e-05	0.000594	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HSPG2—systemic scleroderma	3.19e-05	0.000591	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—NOS3—systemic scleroderma	3.11e-05	0.000575	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CTLA4—systemic scleroderma	3.1e-05	0.000574	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.1e-05	0.000573	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	3.09e-05	0.000572	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CSK—systemic scleroderma	3.08e-05	0.000571	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CTLA4—systemic scleroderma	3e-05	0.000555	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CTLA4—systemic scleroderma	3e-05	0.000555	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	2.99e-05	0.000553	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	2.99e-05	0.000553	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—EDN1—systemic scleroderma	2.97e-05	0.00055	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—CCL2—systemic scleroderma	2.96e-05	0.000548	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—EDN1—systemic scleroderma	2.93e-05	0.000542	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—CCL2—systemic scleroderma	2.92e-05	0.000541	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	2.91e-05	0.000539	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—CTGF—systemic scleroderma	2.89e-05	0.000536	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—NOS3—systemic scleroderma	2.83e-05	0.000525	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	2.82e-05	0.000522	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	2.82e-05	0.000522	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CSK—systemic scleroderma	2.81e-05	0.000521	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—NOS3—systemic scleroderma	2.74e-05	0.000508	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—NOS3—systemic scleroderma	2.74e-05	0.000508	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CSK—systemic scleroderma	2.72e-05	0.000504	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CSK—systemic scleroderma	2.72e-05	0.000504	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	2.67e-05	0.000494	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—CTGF—systemic scleroderma	2.66e-05	0.000492	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—CTGF—systemic scleroderma	2.64e-05	0.000489	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—HSPG2—systemic scleroderma	2.64e-05	0.000489	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	2.58e-05	0.000478	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	2.58e-05	0.000478	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EDN1—systemic scleroderma	2.56e-05	0.000473	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—CTGF—systemic scleroderma	2.55e-05	0.000473	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—CTGF—systemic scleroderma	2.55e-05	0.000473	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	2.55e-05	0.000473	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—CCL2—systemic scleroderma	2.55e-05	0.000471	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—CCL2—systemic scleroderma	2.53e-05	0.000469	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EDN1—systemic scleroderma	2.52e-05	0.000467	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	2.49e-05	0.000461	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	2.47e-05	0.000457	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	2.47e-05	0.000457	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL1A—systemic scleroderma	2.43e-05	0.000449	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD40LG—systemic scleroderma	2.41e-05	0.000446	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL1A—systemic scleroderma	2.35e-05	0.000434	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL1A—systemic scleroderma	2.35e-05	0.000434	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD40LG—systemic scleroderma	2.33e-05	0.000432	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD40LG—systemic scleroderma	2.33e-05	0.000432	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CCL2—systemic scleroderma	2.23e-05	0.000414	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EDN1—systemic scleroderma	2.2e-05	0.000407	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CCL2—systemic scleroderma	2.2e-05	0.000407	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	2.19e-05	0.000406	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EDN1—systemic scleroderma	2.19e-05	0.000405	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—HSPG2—systemic scleroderma	2.11e-05	0.00039	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TGFB1—systemic scleroderma	2.05e-05	0.00038	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CCL2—systemic scleroderma	2.03e-05	0.000376	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CTGF—systemic scleroderma	2e-05	0.00037	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CCL2—systemic scleroderma	2e-05	0.00037	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EDN1—systemic scleroderma	1.93e-05	0.000357	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EDN1—systemic scleroderma	1.9e-05	0.000352	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EDN1—systemic scleroderma	1.9e-05	0.000351	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.89e-05	0.000349	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TGFB1—systemic scleroderma	1.87e-05	0.000347	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	1.83e-05	0.000338	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TGFB1—systemic scleroderma	1.81e-05	0.000336	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TGFB1—systemic scleroderma	1.81e-05	0.000336	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NOS3—systemic scleroderma	1.81e-05	0.000335	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	1.77e-05	0.000327	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	1.77e-05	0.000327	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CCL2—systemic scleroderma	1.75e-05	0.000324	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EDN1—systemic scleroderma	1.73e-05	0.00032	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CCL2—systemic scleroderma	1.73e-05	0.000319	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CTGF—systemic scleroderma	1.6e-05	0.000296	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	1.58e-05	0.000292	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NOS3—systemic scleroderma	1.56e-05	0.000288	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NOS3—systemic scleroderma	1.54e-05	0.000285	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	1.53e-05	0.000282	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	1.53e-05	0.000282	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCL2—systemic scleroderma	1.5e-05	0.000278	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCL2—systemic scleroderma	1.5e-05	0.000277	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MMP9—systemic scleroderma	1.45e-05	0.000269	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NOS3—systemic scleroderma	1.37e-05	0.000254	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NOS3—systemic scleroderma	1.34e-05	0.000248	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NOS3—systemic scleroderma	1.33e-05	0.000247	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NOS3—systemic scleroderma	1.33e-05	0.000246	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NOS3—systemic scleroderma	1.33e-05	0.000246	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCL2—systemic scleroderma	1.32e-05	0.000244	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCL2—systemic scleroderma	1.3e-05	0.00024	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCL2—systemic scleroderma	1.3e-05	0.00024	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL1B—systemic scleroderma	1.26e-05	0.000234	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—NOS3—systemic scleroderma	1.26e-05	0.000233	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MMP9—systemic scleroderma	1.25e-05	0.000231	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MMP9—systemic scleroderma	1.23e-05	0.000228	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL1B—systemic scleroderma	1.22e-05	0.000226	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL1B—systemic scleroderma	1.22e-05	0.000226	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TGFB1—systemic scleroderma	1.2e-05	0.000222	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCL2—systemic scleroderma	1.18e-05	0.000219	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NOS3—systemic scleroderma	1.18e-05	0.000218	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NOS3—systemic scleroderma	1.16e-05	0.000214	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—NOS3—systemic scleroderma	1.16e-05	0.000214	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NOS3—systemic scleroderma	1.16e-05	0.000214	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—NOS3—systemic scleroderma	1.15e-05	0.000213	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—NOS3—systemic scleroderma	1.11e-05	0.000206	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—NOS3—systemic scleroderma	1.11e-05	0.000206	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	1.08e-05	0.0002	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—systemic scleroderma	1.08e-05	0.000199	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—systemic scleroderma	1.07e-05	0.000198	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NOS3—systemic scleroderma	1.05e-05	0.000195	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	1.04e-05	0.000193	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	1.04e-05	0.000193	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFB1—systemic scleroderma	1.03e-05	0.000191	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—systemic scleroderma	1.02e-05	0.000188	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	9.61e-06	0.000178	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—systemic scleroderma	9.44e-06	0.000175	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	9.3e-06	0.000172	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	9.3e-06	0.000172	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—systemic scleroderma	9.29e-06	0.000172	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—systemic scleroderma	9.27e-06	0.000172	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—systemic scleroderma	9.07e-06	0.000168	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—systemic scleroderma	8.86e-06	0.000164	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—systemic scleroderma	8.82e-06	0.000163	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—systemic scleroderma	8.78e-06	0.000162	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—systemic scleroderma	8.78e-06	0.000162	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—NOS3—systemic scleroderma	8.71e-06	0.000161	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—systemic scleroderma	8.45e-06	0.000156	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—NOS3—systemic scleroderma	8.21e-06	0.000152	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—systemic scleroderma	7.78e-06	0.000144	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	7.71e-06	0.000143	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—systemic scleroderma	7.66e-06	0.000142	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	7.64e-06	0.000141	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	7.46e-06	0.000138	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	7.46e-06	0.000138	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—systemic scleroderma	6.96e-06	0.000129	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—NOS3—systemic scleroderma	6.95e-06	0.000129	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	6.35e-06	0.000118	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	6.15e-06	0.000114	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	6.15e-06	0.000114	CbGpPWpGaD
